Neuboron Medtech
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
no.568 Longmian Ave, Jiangning District,...Website
www.neuboron.comRevenue
$8.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Neuboron Medtech
中硼医疗 specializes in the research and industrialization of Accelerator Boron Neutron Capture Therapy (AB-BNCT) products, offering a comprehensive BNCT solution that includes self-developed medical devices, drugs, and software. The company is committed to making BNCT accessible and affordable for patients in need, aligning with the Healthy China strategy while driving innovation in cancer treatment technology. They provide diagnostic equipment, drug supply, radiation protection, planning design, and training services to medical institutions and partners. With a focus on customized solutions, 中硼医疗 aims to establish standardized BNCT comprehensive tumor centers and continuously optimize clinical and research capabilities.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuboron Medtech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Neuboron Medtech had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Neuboron Medtech has new funding data
Congratulate Masked Content for being promoted to Masked Content at Neuboron Medtech
Check out if Neuboron Medtech is spiking on competitors!
Product Launch: Get notified when Neuboron Medtech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neuboron Medtech recently announced quarterly report
Check if Neuboron Medtech has recently received funding, and reach out quickly before it becomes old news!
Neuboron Medtech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Neuboron Medtech
Find 3 more new buyers
Company Profile Activity
Activity Insights
Neuboron Medtech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuboron Medtech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuboron Medtech.
Neuboron Medtech Tech Stack
A closer look at the technologies used by Neuboron Medtech
See more technologies
Neuboron Medtech News & Media
Neuboron Medical Group Advances Cancer Treatment: Introducing Next-Generation Boron Neutron Capture Therapy
NANJING, China--(BUSINESS WIRE)--Neuboron Medical Group (Neuboron) is pleased to announce significant progress in the commercialization of its comprehensive Boron Neutron Capture Therapy (BNCT) solution, marking a new era in the treatment of refractory tumors. On March 26, the Beijing Institute of Medical Device Testing (BIMT) granted Neuboron’s NeuPEX Block-I, an electrostatic accelerator-based BNCT system, its Medical Device Testing Reports. Concurrently, the Center of Drug Examination of theTAE Life Sciences' Neutron Beam System Receives Acceptance, Allowing BNCT Clinical Trials to Begin in China
A Key Component of Neuboron's NeuPex AB-BNCT System, TAE Life Sciences' Neutron Beam System Receives Performance Acceptance and Passes Class III Registration Inspection IRVINE, Calif., April 3, 2024 /PRNewswire/ -- TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy...Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development
NANJING, China--(BUSINESS WIRE)--Neuboron Medical Group announced the most recent outcomes for China's first AB-BNCT IIT-001 and a portfolio of new drug development.China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)
XIAMEN, China--(BUSINESS WIRE)--Neuboron Medical Group announces China's first AB-BNCT cancer research center at XHH has treated 12 patients in investigator-initiated trial setting.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuboron Medtech
Sign Up For FreeTo access detailed company insights
中硼医疗 specializes in the research and industrialization of Accelerator Boron Neutron Capture Therapy (AB-BNCT) products, offering a comprehensive BNCT solution that includes self-developed medical devices, drugs, and software. The company is committed to making BNCT accessible and affordable for patients in need, aligning with the Healthy China stra... Read More
